Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangxi Wuzhou Zhongheng Group CoSHSE:600252 -3.40%46 Interest Coverage is 0.69 as of Jun. 2026, which is 99% below its 10-year median of 73.75. GuruFocus rates SHSE:600252 with a GF Score™ of 46/100 and a GF Value™ of ¥1.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 676 Drug Manufacturers companies, Guangxi Wuzhou Zhongheng Group Co ranks worse than 147928.85% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Guangxi Wuzhou Zhongheng Group Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥10 Mil. Guangxi Wuzhou Zhongheng Group Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-14 Mil.
Guangxi Wuzhou Zhongheng Group Co's interest coverage for the quarter that ended in Jun. 2026 was 0.69.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Guangxi Wuzhou Zhongheng Group Co's Interest Coverage or its related term are showing as below:
SHSE:600252's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 13 * Ranked among companies with meaningful Interest Coverage only.
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Guangxi Wuzhou Zhongheng Group Co Interest Coverage Related Terms
Guangxi Wuzhou Zhongheng Group Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Guangxi Wuzhou Zhongheng Group Co Interest Coverage Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Guangxi Wuzhou Zhongheng Group Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangxi Wuzhou Zhongheng Group Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Guangxi Wuzhou Zhongheng Group Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Guangxi Wuzhou Zhongheng Group Co's Interest Coverage falls into.
Guangxi Wuzhou Zhongheng Group Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) has a Interest Coverage of 0.69 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. This is 99% below median its historical median of 73.75. According to the industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #999999 out of 676 companies in the Drug Manufacturers industry.
Is Guangxi Wuzhou Zhongheng Group Co's Interest Coverage too high?
Guangxi Wuzhou Zhongheng Group Co's current Interest Coverage of 0.69 is 99% below median its 10-year median of 73.75. The Drug Manufacturers industry median Interest Coverage is 13.00. Guangxi Wuzhou Zhongheng Group Co's value of 0.69 is 94.7% below this industry median. Based on the distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #999999 out of 676 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Guangxi Wuzhou Zhongheng Group Co has a GF Score™ of 46/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangxi Wuzhou Zhongheng Group Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #999999 out of 676 companies for Interest Coverage. This places Guangxi Wuzhou Zhongheng Group Co in the lower half of its industry. The industry median Interest Coverage is 13.00. Guangxi Wuzhou Zhongheng Group Co's value of 0.69 is 94.7% below this benchmark. While the company's 10-year median is 73.75 vs. the industry median of 13.00, Guangxi Wuzhou Zhongheng Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 13.00, based on 676 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangxi Wuzhou Zhongheng Group Co's current Interest Coverage of 0.69 is 94.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 13.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangxi Wuzhou Zhongheng Group Co's current Interest Coverage is 0.69, which is 99% below median its own 10-year median of 73.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangxi Wuzhou Zhongheng Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.74, compared to a current price of ¥2.27 — trading 30.5% above its estimated fair value. The current Interest Coverage is 0.69, which is 99% below median its 10-year median of 73.75 and 94.7% below the Drug Manufacturers industry median of 13.00. Guangxi Wuzhou Zhongheng Group Co's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Guangxi Wuzhou Zhongheng Group Co (SHSE:600252), the current Interest Coverage is 0.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) Overvalued in 2026?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co stock appears to be overvalued.
The current stock price of ¥2.27 is trading 30.5% above its estimated GF Value™ of ¥1.74.
GuruFocus considers Guangxi Wuzhou Zhongheng Group Co to be Modestly Overvalued.
Key valuation signals for SHSE:600252:
Interest Coverage: 0.69 (99% below median its 10-year median of 73.75)
GF Value™: ¥1.74 vs. price of ¥2.27 (30.5% above fair value)
Industry Position: 94.7% below the Drug Manufacturers median (#999999 of 676)
No single metric tells the full story. See the SHSE:600252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangxi Wuzhou Zhongheng Group Co Ltd is a Chinese company engaged in the production of Chinese medicines. The company is also involved in real estate and health foods.
46GF Score
Get the complete analysis for SHSE:600252
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600252 has been successfully added to your 
